| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |